Labastida, Mary Joy .
HRN: 23-88-31 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/18/2024
CEFAZOLIN 1GM (VIAL)
06/18/2024
06/24/2024
IV
500mg
Q6H
For ORIF
Waiting Final Action
Indication: Prophylaxis Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes